Postgraduate Medicine 1996: Vol 100 Index

7 Pages·1996·2.5 MB·English

INDEX TO POSTGRADUATE
VOLUME 100 MEDICINE
JULY-DECEMBER 1996
SUBJECTS
ACQUIRED IMMUNODEFICIENCY e Urticaria, diagnosis and treat- ° rey during Penge, di-
SYNDROME: See AIDS ment. 100(2):77* agnosis and treatment. 100(4):131* Ag computer-
AGING ANAPHYLAXIS CANCER: SeeN i phile.(( 0000)0 06 ):25
© Delirium, recognition, evalua- © Recognition and treatment, pre- CARDIOVASCULAR * High-tech presentations. (DD)
tion, and treatment. 100(1):121* venting potentially fatal attacks. ¢ Angina, unstable, _ 100(4):31
© Depression in late life, insights 100(2):87 and treatment. 100(2):13: ¢ Learning and —_ current
into diagnosis and consequences. ANEMIA e Angioedema, Teanaeis and using tthhee Web. (DD)1 3):31
100(4):143* e lron deficiency, iron replace- treatment. 100(2):82 ¢ Readers’ questions and com-
* Depression in late life, special ment therapy, orally or parenter- e Antihypertensive drug therapy, ments. (DD) 100(5):35
— considerations. 100(4): ally. (CR) 100(5):181 sooaan! appropriate agents. ¢ Tips for browsing the World
161* ANGINA PECTORIS: See Cardio- ‘4):89" Wide Web. (DD) 1 _ ):35
e Elder abuse, recognition and vascular diseases * Chest pain, distinguishing car- Videoconferencing systemsfo r
intervention. 100(1):106 ANXIETY diac from noncardiac causes, “telemedicine.” (OD)1 00(1):33
© Hyperlipidemia in elderly, thera- © Relationship to depressive ill- + ae and treatment. 100(6): CONTRAST MEDIA
py. 100(1):145 ness, differential diagnosis, treat- © Radiocontrast nephropathy, risk
e Hypertension, recent findings ment. 100(2):163* ° _ shock in patients factors, evaluation, and treat-
of treatment studies. 100(4):63 APPETITE DISORDERS with hypovolemia, guidelines for . 100(6):88
¢ Increased risk of postoperative ¢ Malnutrition in elderly, diagno- fluid resuscitation. 100(3):248 COST-BENEFIT ANALYSIS
pulmonary complications. 100(5): sis, nutritional replacement thera- ¢ Coronary heart disease in * Clinical practice guidelines to
243 py. 100(1):207* women, gender differences in improve decision making and
© Malnutrition in elderly, diagnosis, ARTHRITIS: See Rheumatic dis- presentation and mana ier keep costs down. (ED) 1 ):17
nutritional replacement therapy. eases
100(1):207* ASTHMA ¢ Hypercholesterolemia, guide- DELIVERY OF HEALTHCARE
¢ Renal disorders in older people, © Reflux-related, diagnosis and lines for screening and treatment. © Addressing crisis oh oooh1 8
safety tips on drug choices and treatment. 100(5):106 100(1):138* infectious diseases. (E 21
= 1 ¢ Risk factor for postoperative © Hypertension. (PN) 100(4):84 * Clinical
eerey complications. 100(5): © Hypertension, effects of smok- gines for improvement. (ED)
*° i nfectious myositis inHI V-positive ing. 100(5):147* 100(3):15
¢ Treatment, preventive strate- ¢ Hypertension in women and ¢ Measures of fa yea
gies. 100(2):105° the elderly, recent findings of formance—HE S teat lan
treatment studies. 100(4):58* Employer Data and Information
e Anaphylaxis, recognition and BACK e Hypertension, preventing or Set) and the NCQA (National
treatment, preventing potentially @ Pain. (PN) 100;6):192 slowing progression of end-stage Commitfotr eQuaelit y Assurance).
fatal attacks. 100(2):87* ¢ Pain, SS, for efficient renal disease. 100(5):164 (ED) 100(6):11
ALCOHOLISM evaluation. 100(6):143 ¢ Hypertension, recommended DEPRESSION
¢ In women, importance of early BEHAVIOR DISORDERS lifestyle modifications. 100(4):75* © Clues in primary care practice,
detection and treatment. 100(4): e Attention-deficit hyperactivity © Hypertension, resistant,s impli- -_ and treatment. 100(1):
221* disorder. (PN) 100(3):338 fied approach to workup. 100(4):
¢ Preventive, public health ap- * Attention-deficit hyperactivity 97* e In peters with fibromyalgia.
proach. 100(1):69° disorder in adults, identification. * Link to cholesterol abnormali- 100(1):159
ALLERGY 100(3):207* ties, advances in treatment. 100(5): In the elderly, insights into
e Anaphylaxis, recognition and BEHAVIORAL MEDICINE 61* nosis and consequences. 00K:
treatment, preventing potentially ¢ Interventions for insomnia. © Mitral valve prolapse. (PN) 100(1):
fatal attacks. 100(2):87* 100(5):198 284
e¢ Asthma, ——. preventive ¢ Psychosocial intervention for de- ¢ Tachycardias, wide-complex,
strategies. 100(2):105 pression in the elderly. 100(4):161 - ifying the mechanism. 100(3): information. (PN) 100(1):
* Rhinitis, allergic and nonal BLEEDING: See Hemorrhage 99
determining cause and prc ae BLOOD CHEMOTHERAPY: See Drugs, anti- © Relationship to anxiety, differ-
appropriate therapy. 100(2):64* ° ge aaeaeeaae diag- neoplastic —_ diagnosis, treatment. 100(2):
. os in eyelid dermatitis. 100(2): nosis. 100(1):22 CHILD ABUSE
231 BLOOD La © identification and intervention. DERMATITIS
© Treatment, preventive strategies. ¢ Control in patients with renal 100(1):103 ¢ Plant, causes, treatment and
100(2):87* impairment slows a of prevention strategies. 100(3):159*
¢ Treatment with immuno’ renal disease. 100(5):1 * Abnormalities, advances in
—— contraindications. BREAST DISEASES treatment to reduce incidence of ¢ End-stage renal disease, pre-
100(2):12: ¢ Cancer, screening and evalua- cardiovascular events. 100(5):61* ventive measures. 100(5):163
tion. (GL) 100(3):180 © Hypercholesterolemia, risk fac- TECHNIQUES
tor in coronary artery disease, ¢ Colonoscopy, bowel prepara-
*Major clinical discussion CALCIUM guidelines for screening and mended methods
CR, Case © Hypercaicemia, mechanisms, treatment. 100(1):138*
CV, Clinical Viewpoint diagnosis, and remedies. 100(6): COLONIC DISEASES: angina.
ital Doc 119° intestinal diseases
CALCULI COLONOSCOPY e Invasive, for Helicobacter py-
GL, Clinical Practice Guidelines e Renal, evaluation and treat- p° ln onp reparation, four recom- lori infection. 100(5):123
PH, Physician-at- ment, prevention of new stone mended methods of colon lavage. ¢ Noninvasive, 10085H)el1i cobacter
PN: Patient Notes formation. 100(6):63* 100(2):203* pylori infection.1 5):1
continued
VOL 100/NO 6/DECEMBER 1996/POSTGRADUATE MEDICINE
ARRR NE TER,
INDEX TO VOLUME 100 CONTINUED
¢ Patch testing for eyelid derma- © For fibromyalgia. 100(1):166 e Esophageal causes of chest
titis. 100(2):233 ¢ For patients with depression pain. 100(6):107
¢ Preoperative pulmonary func- accompanied by symptoms of for gastroesophageal reflux dis- * Gastroesophageal reflux dis-
tion tests to identify patients at anxiety. 100(2):172 ease. 100(5):80 ease, common — ions and
risk for postoperative pulmonary DRUGS, ANTIHISTAMINE DRUGS, PSYCHOTROPIC treatment options. 100(5):95*
¢ For treatment of allergic rhinitis. © For delirium. 100(1):133 ° Gastroesophageal reflux dis-
100(2):67 DRUGS, SIDE EFFECTS ease, current options for short-
DRUGS, ANTIHYPERTENSIVE * From endocrine for ad- - long-term treatment. 100(5):
¢ Choosing a agents, vanced prostate cancer. 1 (3):146
study findings. 100(4):89* e Upper goo tract, © Hepatitis: See Hepatitis
* Special considerationsi n treat- from NSAI ):131* ° anne — fluid
to interpret results. 100(1): 173° ment of women and the elderly. management. 100(3):243
DIARRHEA 100(4):68 EAR DISEASES * Peptic ulcer disease complicat-
¢ Traveler's, prevention. 100(6): DRUGS, ANTI-INFLAMMATORY * Pathologic conditions of exter- ed by Helicobacter pylori infec-
165 . hace canes 100(2): nal ear and auditory canal, guide- tion, diagnosis and treatment.
DIET: See Nutrition 11 lines for identification and treat- 100(5):115*
DIZZINESS ment. 100(3):223* a effects of NSAIDs. 100(5):
¢ Patient information. (PN) 100(4): ¢ Chemotherapfyo r active tuber- 131*
248 —_ bea na e In di nosis of unstable angi- © Traveler's diarrhea, prevention.
DOMESTIC VIOLENCE can- na. 1 14 100(6):165
® Recognition and comprehen- cer. 100(2):217 ELDERLY: See Aging GENITAL DISEASES
sive . 100(1):103* ELECTROCARDIOGRAPHY ¢ Paraphimosis, evaluation and
DRUG THERAPY e Interferon in treatment of © In diagnosis of unstable angi- treatment. 100(4):188
¢ Antihypertensive, choosing chronic viral hepatitis, current na. 100(2):142 ¢ Testicular torsion, diagnosis
late agents. 100(4):89* ions. 100(3):55” e In ———— of wide-complex and t . 100(4):189
° bination, for Helicobacter ¢ Interferon therapey d chronic tachycardias. 100(3):265 * Uterine prolapse, indication for
pylori infection. 100(5):123 viral hepatitis. 100(3) EMERGENCY hysterectomy. 100(6):136
e For gastroesophageal reflux DRUGS,A ¢ Urologic emergencies, over- GERIATRICS: See Aging
disease, options for short- and NODE BLOCKER view of conditions affecting kid- CLINICAL
pica treatment. 100(5):79 ¢ For wide-complex tachycardia, ney, ureter, bladder, le, and * Breast cancer, screening and
restart TOOT eee when to administer. 100(3):272 urethra. 100(4):177* evaluation. (GL) 100(3):180
00(1):1 DRUGS, BRONCHODILATOR ¢ Urologic emergencies, trauma ¢ Pediatric immunization. (GL)
p. y myo eens choice of agents — 100(2): injuries and of con- 100(5):213
and effects. 100(5):202 1 ditions affecting penis, scrotum, GYNECOLOGY: See Obstetrics/
* For kidney diseases in the el- DRUGS, CORTICOSTEROID and testicles. 100(4):187* Gynecology
derly, considering age-related ¢ For treatment of allergic rhinitis. ENDOCRINE DISORDERS
(6):44 100(2):69 © Hypercaicemia, mechanisms, HEARING DISORDERS
* For nephrolithiasis. 100(6):71 ¢ For treatment of severe asthma —_— and remedies. 100(6): ¢ Loss, clues to pathologic con-
¢ For treatin —_—, in flare-ups. 100(2):118 119° ditions of auditory canal, diagno-
smokers. 100(5):1 DRUGS, HISTAMINE ENDOSCOPY sis and treatment. 100(3):223
* For unstable angina. 100(2):149 ANTAGONIST © In detecting juodenal u!- HEART DISEASE: See Cardiovas-
© Interferon for chronic viral hep- e For gastroesophageal reflux cers in patients taking NSAIDs. cular diseases
atitis. 100(3):68 disease. 100(5):79 100(5):136 HEMATOLOGIC DISEASES
© Interferon for chronic viral hep- ENVIRONMENTAL HAZARDS ¢ Associated with parvovirus B19
atitis, limited use. 100(3):55* — air pollution. (PN) 100(2): infection. 100(1):239
DRUGS, ADVERSE REACTION HEMORRHAGE
© Drug-induced lupus, case reiat- ¢ Low-frequency magnetic fields, * Distinguishing between
ed to quinidine. (CR) 100(3):299 role in etiology of cancer, current —_ and hematemesis. 100(1):
¢ Drug-induced nephrotoxicity, issues. 100(2):183*
high-risk situations, prevention of EXERCISE HEPATITIS
renal damage. 100(6):83* for prostate cancer. 100(3):112 ¢ Role in treatment of fibromyal- ¢ A, vaccine, overview and rec-
DRUGS, ANALGESIC DRUGS, HYPNOTIC gia. 100(1):166 ommendations for use. 100(4):117
© For treatment of chronic pain. * For treatment of insomnia, * To prevent or control hyperten- © Viral, chronic, interferon thera-
100(3):283 choice of agents and effects. sion. 100(4):77 py. 100(3):68 :
DRUGS, 100(5):202 EYE DISORDERS * Viral, chronic, use of interferon
ENZYME (ACE) INHIBITOR DRUGS, LEUKOTRIENE INHIBITOR © Eyelid dermatitis, causes, diag- in treatment. 100(3):55*
® Beneficial effects in diabetic e In dev it for treatment of nosis, and treatment. 100(2):231* HORMONES
asthma. 100(2):112 ¢ Endocrine
¢ Risk for acute renal failure. DRUGS, LIPID-LOWERING FEVER
100(6):99 ¢ HMG-CoA reductase inhibitors, © Typhoid, vaccine, overview and ¢ Hormone replacement therapy
DRUGS, ANTIARRHYTHMIC pharmacologic actions, anatomic recom i for use. 100(4): for eee women with
¢ For patients with ventricular effects, and effects on mortality. 121 coronary heart disease. 100(3):195
tachycardia. 100(3):272 100(5):61* FIBROMYALGIA HYPERTENSION: See Cardiovas-
DRUGS, ANTIBIOTIC DRUGS, — and treatment. 100(1): cular diseases
* Aminoglycosides, risk of neph- ANTI-INFLAMMATORY (NSAIDs) HYPOVOLEMIA
rotoxicity. 100(6):94 — chronic pain relief. 100(3): FLUID THERAPY e Emergency fluid management.
¢ Chemoprophylaxis, postsple- * Oral rehydration therapy for hy- 100(3):243*
nectomy infection. 100(1):198 ne effects. 100(5): povolemia. 100(3):244
© For treatment of bacterial pyo- 131° FOOT DISORDERS IMMUNIZATION
dermas in adults, common regi- — information. (PN) 100(5): ¢ Gout, unusual presentations, ¢ New and improved vaccines,
mens. 100(3):313 tips for accurate diagnosis. (CR) most le use. 100(4):113*
© Resistance, public health threat. ¢ Risk for renal dysfunction or 100(1):253 ¢ Pediatric, recommendations.
(ED) 100(5):15 nephrotoxicity. 100(6):97 (GL) 100(5):213
DRUGS, ANTIDEPRESSANT OPIOID GASTROINTESTINAL DISEASES ¢ Pneu vaccine to pre-
¢ For depression. 100(11)) :93 ¢ For chronic pain management. * Bowel preparation before vent postsplenectomy infection.
© For depression in the elderly, 100(3):283 colonoscopy, four recommended 100(1):198
special considerations. 100(4):162 — of colon lavage. 100(2): ¢ Requirements for international
travel. 100(6):159
VOL 100/NO 6/DECEMBER 1996/POSTGRADUATE MEDICINE
IMMUNOTHERAPY e Renal colic, diagnosis and NEOPLASMS ¢ Pathologic conditions of exter-
¢ For treatment of allergy, indica- treatment. 100(4):11 77 * Adnexal masses, indication for nal ear and audit , identi-
tions, contraindications. 100(2): KNEE INJURIES hysterectomy. 100(6):136 fication and treatment. 100(3):
123* ¢ Patellar tendon rupture, timely ¢ Bladder cancer, diagnosis and
IMPOTENCE recognition and management. treatment. 100(2):217*
¢ Complication after radical (CR) 100(2):241 ¢ Breast cancer, screening and PAIN
prostatectomy. 100(3):129 evaluation. (GL) 100(3):180 © Chest, noncardiac, causes, di
INCONTINENCE LABORATORY INVESTIGATION e Cancer, possible cause of low nosis, and treatment. 100(6):10
¢ Complication after radical pros- * Prostate-specific antigen (PSA) back pain. 100(6):146 ¢ Chronic, effective pharmaco-
testing for prostate cancer, key © Cancer, role of low-frequency management. 100(3):281*
considerations. 100(3):90* —- fields in etiology. 100(2): ¢ Fibromyalgia, diagnosis and
treatment. 100(6):137 ¢ Tuberculin skin testing, inter- 183° treatment. 1s Oai153
INFANTS pretation of results. 100(4):202 e External ear, diagnosis and © Low back. (PN) 10000(64) :192
¢ Effects of maternal drinking. e Urinalysis, knowing when to or- t 00(3):228 ¢ Low back, pnb for effi-
100(4):224 der and interpreting results. ¢ Malignancy, cause of hypercal- cient evaluation. 100(6):143*
INFECTION 100(1):173* cemia, diagnosis and treatment. © Pelvic, indication for hysterec-
¢ Bacterial pyodermas, recogni- LIVER DISEASES 100(6):119 tomy. 100(6):135
tion and treatment. 100(3):311* ¢ Chronic viral hepatitis, interfer- ¢ Prostate cancer, advanced PATIENT COMPLIANCE
° a of new diseases, on therapy. 100(3):68 a key points in man- * Noncompliance with treatment,
scope of problem. (ED) 100(5):15 ¢ Chronic viral hepatitis, use of agement. t 21 factor in resistant hypertension.
© Helicobacter pylori, in patients interferon in treatment. 100(3):55* ¢ Prostate cancer, follow-up after 100(4):98
with gastric disease, diagnosis LUNG DISEASES therapy. 100(3):125* PATIENT EDUCATION
and treatment. 100(5):115* e Marked by hemoptysis, evalua- * Prostate cancer, localized, ¢ Attention-deficit hyperactivity
¢ Infectious myositis, increasing tion and management. 100(1):227* it options, pros and cons. . (PN)1 ¥3 38
incidence, — and treat- LUPUS ERYTHEMATOSUS, 100(3):105* —— 99
ment. 100(2):193 SYSTEMIC © Prostate cancer screening, key
¢ Parvovirus ee , associated ¢ Drug-induced, case related to considerations. 100(3):90*
diseases. 100(1): use of quinidine. (CR) 100(3):299 NEUROLOGIC MANIFEST.
* Pelvic, chronic, aaa erec- e Attention-deficit hyperactivity
tomy in treatment. 100(6):137 MALARIA disorder in adults, identification.
e Risk after splenectomy, treat- ¢ Prevention in internationai trav- 100(3):207*
ment strategies. 100(1):195* elers. 100(6):169 © Dizziness. (PN) 100(4):248
¢ Travel-related, immunizations MALPRACTICE © Neurodeficit disordersa s 1001)-284v alve prolapse. 82
and other preventive strategies, ¢ National Practitioner Data Bank of low back = 100(6):149
a for information. 100(6): (NPDB), intended use, economic e Pain: See Pain © Nonsteroidal anti-inflammatory
159° issues. (ED) 100(1):15 NUTRITION drugs (NSAIDs). (PN) 100(5):266
¢ Tuberculosis, recommenda- MEDICAL PRACTICE © Dietary adjustments to prevent ¢ Smoking cessation to reduce
tions for screening, prevention, ® Clinical practice guidelines as or control hypertension. 100(4):75 cardiovascular of nicotine.
and treatment. 100(4):201* engines for improvement. (ED) * Dietary modifications to slow 100(5):147*
e Urinary tract, current cost- 100(3):15 progression of renal disease. © Strategy for preventing post-
effective management strategies. ¢ Improving decision-making 5):174 splenectomy infection. 10001):201
100(5):229* process with clinical practice ¢ Iron replacement therapy, oral PEDIATRICS
INFLAMMATION guidelines. (ED) 100(2):17 or parenteral, for iron deficiency © Child abuse, identification and
Eyelid dermatitis, causes, diag- ¢ Measures of professional per- anemia. (CR) 100(5):181 intervention. 100(1):103
nosis, and treatments. 100(2): 231* formance—HEDIS (Health Plan * Mainutrition in elderly, —_ ¢ Hypovolemia in infants and
e Gout, unusual presentations, Employer Data and Information sis, nutritional children, be fluid man-
tips for accurate diagnosis. (CR) Set) and the NCQA (National py. 100(1):207* % :
100(1):253 Committee for Quality Assurance). ¢ Immunization recommenda-
INJURIES: See Trauma (ED) 100(6):11 OBESITY tions. (GL) 100(5):213
INSOMNIA ¢ National Practitioner Data Bank * Increased risk of postoperative ¢ Varicella virus vaccine, over-
¢ Causative factors, behavioral (NPDB), intended use, economic pneumonia. 100(5):243 view and recommendations for
and therapy. 10065): issues. (ED) 100(1):15 e Weight reduction to reduce use. 100(4):113
195" © Preserving personal and pro- blood pressure. 100(4):76 PHYSICIANS
INTERFERON fessional mentoring in medicine. ¢ Helpful and interesting World
+ chronic viral hepatitis. 100(3): (ED) 100(4):15 ¢ Hysterectomy for benign gyne- Wide Web sites. (DD) 1 ):35
¢ Readers’ questions ard com- cologic disorders, overview of ¢ Learning opportunities on the
e In treatment of chronic viral ments on using computers in prac- when and why. 100(6):133* Web. (DD) 100(3):31
hepatitis, current considerations. tice. (DD) 100(5):35 ° , effects on coronary © Mentoring, i
100(3):55* e Videoconferencing, the emerg- heart disease in women. 100(3): tion along with satisfac-
IRON ~. market for “telemedicine.” 191* tion. (ED) 100(4):15
© Deficiency anemia, oral or par- (DD) ) 100(1):33 * Urinary caiculi during preg- e Using tech in -
enteral iron replacement therapy. METABOLIC nancy, diagnosis and treatment. tions. (90) 100(4) 1
(CR) 100(5):181 © Hypercalcemia, mechanisms, 100(4):131* PLANTS
diagnosis, and remedies. 100(6): OCCUPATIONAL DISEASES ¢ Cause of dermatitis, possible
KIDNEY DISEASES 119° ¢ Exposure to Mycobacterium causes, treatment and i
¢ End-stage renal disease, mea- ‘AL DISORDERS tuberculosis, routine screening. strategies. 100(3):159*
sures to prevent it or slow pro- e Fibromyalgia, diagnosis and 100(4):217 POLLUTION
gression. 100(5):163* °153* © Role of low-frequency magnet- © Indoor air. (PN) 100(2):252
* Hypovolemia, em e Infectious myositis, increasing ic fields in cancer. 100(2):183 PREGNANCY: See Obstetrics/Gy-
00( incidence, diagnosis and treat- OCULAR DISORDERS: See Eye
ment. 100(2):193* isorders PREVENTIVE MEDICINE
© Low back pain. (PN) 100(6):192 e Alcoholism, public health ap-
¢ Nephrolithiasis, ‘evaluation and ¢ Low back pain, guidelines for proach combining medical, psy-
treatment, prevention of new efficient evaluation. 100(6):143* chological, and social interven-
stone formation. 100(6):63* ¢ Pateliar tendon rupture, timely tions. 100(1):69*
* Nephrotoxicity, drug-induced, recognition and management. ¢ Immunization and other strate-
high-risk situations, prevention of (CR) 100(2):241 i¢s to prevent travel-related in-
renal damage. 100(6):83* = teak1 00(6):159*
VOL 100/NO 6/DECEMBER 1996/POSTGRADUATE MEDICINE
TO VOLUME 100 CONTINUED
* Lifestyle modifications to pre- * Low-frequency magnetic fields SHOCK TRAUMA
v1e0n0(t4 ):o7r5 * control hypertension. e183° ee 100(2): * Circulatory, in patiewnitth shy - t¢ racAtc,u teev ailnujautriyo no f agnedn itmoaunriangaer-y
¢ Measures to prevent infection * Tuberculosis, recommendations ment. 100(4):194
in patients after splenectomy. for screenin , prevention, and ¢ Indication for splenectomy,
100(1):198 treatn 1 (4):201* * Cancer, manifested by neo- treatment strategi ~ = reduce
© Pediatric immunization. (GL) * Vaccines, new and improved, plasmsof external ear. 100(3):228 risko f infection. 1
10085. 213 most appropriate use. — 113° ¢ Common skin infections, recog- © Patellar tendon = timely
* Preventing end- renal dis- PULMONARY DISEASES: See Lung nition and treatment. Faces «gg hl recognition and management.
ease in patients with les and diseases: ¢ Eyelid dermatitis, diag- (CR) 100(2):241
—— 100G5):163 nos, and treatments, 110000(2() :231* TRAVEL
Preventive therapy for tubercu- QUAOLF IHEATLTHYCAR E ¢ Plant dermatitis, causes, treat- e Infectious disease, immuniza-
losis in high-risk groups. 100(4): ® Clinical improvements with use ment and prevention strategies. tions and other preventive strate-
202 ¢ practice guidelines. (ED) 100(3): 100(3):159* gies for travel-related infections.
¢ Vaccines, new and improved, ¢ Urticaria, — and treat- 100(6):159*
most appropriate use. 100(4):113* ¢ Improving decision-making ment. 100(2):77* TUBERCULOSIS
PROSTATIC DISEASES process with clinical practice SLEEP DISORDERS e Recommendations for screen-
¢ Advanced (metastatic) prostate guidelines. (ED} 100(2): ¢ In patients with fibromyalgia. ing, prevention, and treatment.
cancer, key points in manage- ¢ Measures of professional - 100(1):159 (4):201*
ment. 100(3):139" formance HEDIS (Health Pian ¢ Insomnia, causative factors, See Neoplasms
© Cancer, follow-up after therapy. Employer Data and Information behavioral and pharmacologic
100(3):125°* Set) and the NCQA (National therapy. 100(5):195 ULCER
¢ Cancer, localized, treatment Committee for Quality Assur- SMOKING ¢ Peptic, complicated by Heli-
= pros and cons. 100(3): ance). (ED) 100(6):11 © Effects on cardiovascular sys- cobacter pylori infection, diagno-
105° ¢ National Practitioner Data Bank term. 100(5):147* sis and treatment. 100(5):115*
* Cancer, screening, key consid- (NPDB), intended use, economic * Increases risk for postoperative ® Side effoef NcSAtIDs . 100(5):132
erations. 100(3):90° issues. (ED) 100(1):15 — complications. 100(5): TRACT DISORDERS
¢ Prostatitis and prostatic ab- 1 * Infection, current cost-effective
scess, diagnosis and treatment. RADIOGRAPHY SOCIAL PROBLEMS ——— strategies. 100(5):
100(4):180 ¢ Nephrotoxicity induced by con- ¢ Domestic violence, compre-
PSYCHIATRIC/PSYCHOSOCIAL trast media. 100(6):88 hensive management strategy. © Pyelonephritis and renal ab-
DISORDERS RADIOTHERAPY 100(1):103* scess, diagnosis and treatment.
e Alcoholism in women, impor- ¢ For organ-confined prostate SPLENIC DISEASES 100(4):178
tance of early detection and treat- cancer. 100(3):111 ¢ Postsplenectomy care to de- UROLOGIC DISEASES
ment. 100(4):221° RENAL DISEASES: See Kidney crease risk of infection. 100(1): ¢ Acute urinary retention, diagno-
¢ Alcoholism, co public diseases sis and treatment. 100(4):179
health approach. 100(1):69 RESPIRATORY DISEASES ry man ny ¢ Bladder cancer, diagnosis and
¢ Anxiety and depressive disor- Asthma, treatment, preventive ¢ Recognition and management. treatment. 100(2):217*
ders, i strategies. 100(2):105* 100(1):104 e Emergencies, management of
* Chronic cough, extraesophageal STRESS trauma injuries and conditions af-
e Attention-deficit hyperactivity mpinaiation ¢ Physiologic responses, role in fecting penis, scrotum, and testi-
disorder. (PN) 100(3):338 reflux disease. 100(5):106 fibromyalgia. 100(1):153 cles. 100(4):187*
© Attention-deficit hyperactivity j° oe by hemoptysis, evalua- SUICIDE e Emergencies, overview of con-
disorder in adults, identification. and management. 100(1):227* ¢ Consequence of untreated de- ditions affecting kidney, ureter,
100(3):07° p° y ee complications from pression in the eiderly. 100(4):50 bladder, prostate, and urethra.
* Delirium, recognition, evalua- surgery, preoperative evaluation ¢ Risk in patients with depres- 100(4):177*
ton,a nd treatment. 100(1):121* to identify patients at increased sion. 100(1):88 © End-stage renal disease, mea-
* Depression. (PN) 100(1):99 risk. 100(5):241* SURGERY sures to prevent it or slow pro-
and affective disor- ¢ Rhinitis, allergic and nonaller- ¢ Antireflux for long-term control gression. 100(5):163*
on in patients with fibromyaigia. gic, determining cause and of gastroesophageal reflux dis- © Fournier’s rene, evaluation
1OOtty: 159 pees appropriate therapy. ease. 100(5):89 and treatment. 100(4):193
© Depression in late life, insights 100(2):64 ¢ Hysterectomy for benign gyne- ¢ Nephrolithiasis, evaluation and
into diagnosiasn d consequences. ¢ Tuberculosis, recommenda- cologic disorders, overview of treatment. prevention of new
100(4):143* tions for screening, prevention, when and why. 100(6):133* stone formation. 100(6):63*
© Depression in late life, special and treatment. 100(4):201* © Preoperative pulmonary evalu- * Nephrotoxicity, drug-induced,
— considerations. 100(4): RHEUMATIC DISEASES ation, identifying patients at risk Ss, prevention of
¢ Fibromyalgia, oo and for complications. 100(5):241*
* Depression, manifestations, di- treatment. 100(1):153* ¢ Prostate, for cancer, surgical ¢ Periurethral abscess, diagnosis
and treatment. 100(1):85* ¢ Gout, unusual presentations, options. 100(3):107 and treatment. 100(4):183
¢ Domestic violence, compre- tips for cre, diagnosis. (CR) omy, postsurgical care ¢ Prostate cancer, advanced
hensive t. 100(1):103* 100(1):253 a decrease risk of infection. (metastatic), key points in man-
* Insomnia, causative factors, © Systemic lupus losus, 100(1):195* 00(3):139*
behavioral and pharmacologic drug-induced, case related to
therapy. 100(5):195* quinidine. (CR) 100(3):299 THERAPEUTICS
© Role in patients with noncar- © Immunotherapy for allergic sen- ¢ Prostate cancer, localized,
diac chest pain. 100(6):108 SCREENING sitivities, indications, contraindica- py te tenes 100(3):105*
PUBLIC HEALTH * Cholesterol, risk factforo cror o- tions. 100(2):123* e cancer, screening, key
¢ Alcoholism, public health ap- + Porb oastc ane1 00(1):138 ¢ Investigational therapies for considerations. 100(3):90*
proach in education, prevention, Ang breast cancer. (GL) 100(3): prostate cancer. 100(3):112 * Renal disorders in the elderly,
and intervention. 100(1):69* * |ron replacement therapy, oral safety tips on drug choices and
* Community resources for vic- °y * tuberculosis, recommenda- or parenteral, for iron deficiency doses. 100(6):44
tims of domestic violence. 100(1): tions for screening, prevention, anemia. (CR) 100(5):181 © Stress incontinence in women,
114 ¢ Percutaneous transluminal role of hysterectomy in treatment.
a° infectious diseases, coronary —— ty for unstable 100(6):137
problem. (ED) 100(5):15 ations. 100(3):90* angina. 100(2):153 e Urethral stricture, evaluation
= Indoora ir pollution. (PN) 100(2): SEXUAL DISORDERS TOBACCO and management. 100(4):183
¢ Impotence following radical * Nicotine’s effects on cardiovas- © Urinary calculi pregnancy,
——s treatment. 100(3): cular system. 100(5):147* or and treatment. 100(4):
1 131°
VOL 100/NO 6/DECEMBER 1996/POSTGRADUATE MEDICINE
VACCINATION: See Immunization ¢ Parvovirus B19 infection, as- WOMEN ¢ Hypertension, recent findings
VERTIGO sociated diseases. 100(1):239* ¢ Alcoholism, increasing inci- of treatment studies. 100(4):60
¢ Patient information. (PN) 100(4): dence, importance of early de- ° eS age er for benign gy-
V4I8R AL DISEASES We ATDEisRt-uErLbEaCnTcReOsL YiTnE elBdeArLlAy NCpEa - =1° and treatment. 100(4): disorders, overview of
¢ Hepatitis, chronic, interferon tients, age-related changes in © Gender differences in presen-
therapy. 190(3):68 kidney function. 100(6):44* tation and of coro- nary
* Hepatitis, chronic, use of inter- nary heart disease, effects of ment. 100(4):131*
feron in treatment. 100(3):55* menopause. 100(3):191* WOUNDS/INJURIES: See Trauma
AUTHORS
AIMI G BREEN KJ FREEDMAN A
See Crosignani PG See El-Mallakh RS Follow-up after therapy for
ALIH prostate cancer: Treating the
Introduction to symposium on CARROLL JA problems and caring for the man.
— renal problems. 100(6): Common bacterial pyodermas: 100(3):125
Taking aim oaks — most likely FRIERSON RL
Renal disease in the elderly: pathogens. 100(3): See Biondell RD
Distinctive disorders, tailored CASEY DA
treatments. 109(6):44 Delirium: Quick recognition, GANDHI S
AMIDON TM careful evaluation, and appropri- Resistant hypertension: Sug- 4 reasons
Introduction to symposium on ate treatment. 100(1):121 gestions for dealing with the to help your patients kick the
hypertension. 100(4):53 CLARK CL it. 100(6):147
Complications of gastro- KORETZR L
esophageal reflux disease: Chronic viral and use
A new malpractice defense: Esophagitis, acid laryngitis, and of interferon: Whom are we
Common sense. (PH) 100(1):29 beyond. 100(5):95 treating? 100(3):55
To sigh for: Diseases that don’t COLICE GL
make our day. (PH) 100(5):31 Hemoptysis: Three quesiions RR
Top 10 easy eats: A physician's that can direct management. the gray zone: How
bread and butter. (PH) 100(4):27 100(1):227 Allergic and nonallergic rhinitis: clinical practice guidelines can
CONNELLY C Directing medical therapy at spe- improve the decision-making pro-
BADALAMENT RA Easing low back pain. (PN) cific symptoms. 100(2):64 cess. (ED) 100(2):17
Bladder cancer: Current diag- 100(6):192 introduction toa n on LAVENDER RC
nostic methods and treatment Patients with low back pain: allergy. 100(2):59 See Mohr DN
options. 100(2):217 How to identify the few who need LEVINE RJ
BAQUIS G extra attention. 100(6):143 HAHN G Patellar tendon rupture: The im-
See O’Neill DS CONRAD DA See Freedman A portance of timely recognition
New and improved vaccines: HOOD VL and repair. (CR) 100(2):241
Promising weapons against vari- End-stage renal disease: Mea- LIPPMANN SS
cella, hepatitis A, and typhoid sures to prevent it or slow its pro- Introductiont o
Options in antihypertensive fever. 100(4):113 gression. 100(5):163
drug therapy: Help in choosing CROSIGNANI HORWITZ B See also Blondell RD; Casey DA;
from among the many agents. i gyne- See Clark CL El-Mallakh RS; Pary R: Steiner RP
cologic disorders: When and HOUSHIARA M LOVE N
why? 100(6):133 Urinary calculi pregnan- Forgotten men? epeeeton
cy: When are caufsor econ - comi . 100(3):
cern? 100(4):131 See also Freedman A; Luttge S;
HOWARDR B Taub M; Williams TR
Life at Windy Acres. (PH) 100(3):21 LUTTGE S$
Screfore pronstatie cnancegr: I si t
j other INSTIFOTR UCLTINIECA L a service or a disservice? 100(3):90
preventive strategies. 100(6):159 Hypercalcemia: Mechanisms, SYSTEMS INTEGRATION
BLAKE-INADA LM differential diagnosis, and reme- Breast cancer screening and
Unstable angina: Strategies to dies. 100(6):119 evaluation. (GL) 100(3):180
minimize myocardial injury. DMOCHOWSKI RR Pediatric immunization. (GL)
100(2):139 See Samm BJ 100(5):213 Noncardiac chest pain: Where
BLONDELL RD does it start? 100/6):107
Alcoholism: Taking a preventive, EL-MALLAKHRS JANEIRA LF MISDOPAJI J
public health approach. 100(1):69 Clues to depression in primary Wide-complex tachycardias: Urinalysis: When—and when
BONAGURA AF care practice. 100(1):85 The i of i the not—to order. 100(1):173
Helicobacter pylori infection: ERCOLEC J mechanism. 100(3):259 MOFFITT MP
The importance of eradication in See Houshiar AM JENSENH B Tuberculosis: Recommendations
patients with gastric disease. See Conrad DA for screening, prevention, and
100(5):115 FEDERMAND G JUCKETT G treatment. 1004-201
BRADY WM ae lives. (PH) 100(6):19 Plant dermatitis: Possible cul-
Gastroesophageal reflux dis- FEIFEL prits go far beyond poison ivy. Preoperative pulmonary evalu-
ease: The long and the short of Attention-deficit hyperactivity 100(3):159 ation: Identifying patients at in-
therapeutic options. 100(5):76 disorder. (PN) 100(3):338 creased risk for complications.
Attention-deficit hyperactivity KAPLAN B 100(5):241
disorder in adults. 100(3):207 See Swain RA continued
VOL 100/NO 6/DECEMBER 1996/POSTGRADUATE MEDICINE
WITH EVOLUTION COMES CHANGE.
INDEX TO VOLUME 100 CONTINUED
MONTGOMERY E O'NEILL DS POTTS JF REINERTSEN JL
See Swain RA Infectious myositis: A tropical ‘Dear Digital Doc...’ (DD) 100(5):35 See Mosser G
MORAL L disease steals out of its zone. ir REYNOLDS E
See O'Neill DS 100(2):193 in women and the
MORRIS RJ OSTERHOLM MT elderly: Some puzzling and some
Asthma: Specific preventive Emerging infectious diseases: sions of kilobits and gigabytes expected findings of treatment
strategies. 100(2):105 A real public health crisis? (ED) dancing through your head? (DD) studies. 100(4):58
MOSSER 100(5):15 100(6):25 RICH MW
Healthcare guidelines as en- OSTROWSKI VB Learning on the Web. (DD) Drug-induced lupus: The list of
gines for improvement. (ED) Pathologic conditions of the 100(3):31 — — (CR) 100(3):299
100(3):15 ear and auditory canal. Videoconferencing systems:
100(3): 223 ‘Telemedicine’ has arrived. (DD) Ieeoduction to symposium on
NESSE RE 100(1):33 peptic acid disease. 100(5):75
Feeling hopeless and helpless: aw ens pee way through the
When anxiety symptoms coexist Eyelid dermatitis: A common, of- (DD) 100(2):35 SAADEH C
= depressive disorder. 100(2): taen e rash. 100(2):231 See Uy JP
1 QADRI SM SALVATORE JR
NGUYEN PL Sesteant of insomnia: Getting See Qari M Low-frequency magnetic fields
See Misdraji J to the root of sleeping problems. QARIM and cancer: What you should
NORTH CS 100(5):195 Parvovirus B19 infection: Asso- know and what to tell your pa-
Alcoholism in women: More PEARSON sP ciated diseases, common and tients. 100(2):183
common—and serious—than you Gastrointestinal effects of uncommon. 100(1):239 SAMM BJ
might think. 100(4):221 NSAIDs: Difficulties in detection Urologic emergencies: Condi-
NUWAYHID N and management. 100(5):131 RACKLEY CE tions affecting the kidney, ureter,
See Uy JP PFLEDERER TA Advances in treatment of bladder, prostate, and urethra.
Emergency fluid management cholesterol abnormalities: The 100(4):177
OGOREKC P for hypovolemia. 100(3):243 role of HMG-CoA reductase in- continued
See Brady WM hibitors. 100(5):61
VOL 100/NO 6/DECEMBER 1996/POSTGRADUATE MEDICINE
INDEX TO VOLUME 100 CONTINUED
Urologic emergencies: Trauma STACEY BR TRIVEDI BK WILLIAMST R
injuries and conditions affecting Effective management of chronic Nephrolithiasis: How it Treatment of localized prostate
the penis, scrotum, and testicles. pain: The analgesic dilemma. and what to do about it. 100(6): 63 cancer: Choosing the best alter-
100(4):187 100(3):281 native. 100(3):105
SANTIESTEBANH STEINER RP Uv JP WISE GR
See Gandhi S Domestic violence: Do you know Unusual presentations of gout: Hyperlipidemia: When does treat-
SCHERVISHE W when and how to intervene? Tips for accurate diagnosis. (CR) ment make a difference? 100(1):
See BadalamentR A 100(1):103 100(1):253 138
SCHOENWETTER wr SUDHIR K WISINGER DB
Safe allergen immunotherapy: See Zeliner C VAAMONDE CA Urinary tract infection: Current
The correct allergen, the appro- SVEUM RJ See Thatte L
priate patient, the adequate dose. Urticaria: The Seapets challenge VANSICKLE K aSee z
100(2):123 of hives. 100(2):77 See Casey DA; Steiner RP WRIGHT JC
SCHULTZ TT SWAINR A VERCELLIN! P See El-Mallakh RS
See Wise GR lron deficiency anemia: When is See Crosignani PG WYATT R
SETNESS PA parenteral therapy warranted? VILLABLANCA AC Anaphylaxis: How to recognize,
Anti-inflammatory drugs. (PN) (CR) 100(5):181 Coronary heart disease in treat, and prevent potentially fatal
100(5):266 women: Gender differences and attacks. 100(2):87
Dizziness. (PN) 100(4):248 TAUB M effects of menopause. 100(3):191
a air pollution. (PN) 100(2): Advanced prostate cancer: En-
docrine therapies and palliative WEBB WK
Major depression. (PN) 100(1):99 measures. 100(3):139 See Pary R simply a matter of not eating
Mentoring: Leaving a legacy of THATTE L WIET RJ enough? 100(1):207
opportunity and responsibility. Drug-induced nephrotoxicity: See Ostrowski VB ZELLNER C
(ED) 100(4):15 The crucial role of risk factors. WILKE WS Lifestyle modifications for hy-
Sizing up our professional per- 100(6):83 Fibromyalgia: Recognizing and pertension: The many benefits
formance: Can we use HEDIS as TOBIAS CR addressing the multiple interrelat- are worth the effort. 100(4):75
a springboard to improvement? See Pary R ed factors. 100(1):153 ZISOOK S
(ED) 100(6):11 TOOSON JD WILLIAMS BJ Depression in late life: Diagno-
What do you know about the Bowel preparation before ‘I need a referral.’ (PH) 100(2):29 sis, course, and consequences.
NPDB? (ED) 100(1):15 : Choosing the best WILLIAMS DN 100(4):143
MS lavage regimen. 100(2):203 Postsplenectomy care: Strate- Depression in late life: os
gies to decrease the risk of infec- oe in treatment. 100(4):
tion. 100(1):195
CHANGE YOUR REGIMEN.
© McN/OPC 1996 08K0842J